This patent covers the use of hematopoietic stem cells to generate dendritic cells. The dendritic cells disclosed are able to elicit an antitumor immune response.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.